CIK 0001157601 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 958.4 M | 0 | ||
| Net income (USD) | -83.9 M | |||
| Diluted EPS (USD/shares) | -17.23 | -14.63 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-28 | 144 | 144 | |
| 2026-09-11 | 4 | FORM 4 | 2026-09-09 |
| 2026-09-11 | 144 | 144 | |
| 2026-09-09 | 144 | 144 | |
| 2026-08-20 | 4 | FORM 4 | 2026-08-17 |
| 2026-08-20 | 144 | 144 | |
| 2026-08-18 | 4 | FORM 4 | 2026-08-15 |
| 2026-08-18 | 3 | FORM 3 | 2026-08-11 |
| 2026-08-12 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-08-11 |
| 2026-07-30 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-30 | 8-K | 8-K items 2.02,9.01 | 2026-07-30 |
| 2026-07-29 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-20 | 4 | FORM 4 | 2026-07-17 |
| 2026-07-20 | 144 | 144 | |
| 2026-06-18 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-18 | 4 | 4 | 2026-06-17 |
| 2026-06-17 | S-8 | FORM S-8 | |
| 2026-06-17 | 8-K | FORM 8-K items 5.02,5.07,9.01 | 2026-06-16 |
| 2026-06-01 | 4 | FORM 4 | 2026-06-01 |
| 2026-06-01 | 144 | 144 | |
| 2026-05-22 | 4 | FORM 4 | 2026-05-22 |
Forms on file (last 1,000): 4 398, 8-K 166, 144 85, 10-Q 48, SC 13G/A 41, SC 13D/A 35, 3 32, 424B5 28. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=MDGL (0.002 USD), /gw/filings/filings?ticker=MDGL&form=8-K, /gw/filings/facts?ticker=MDGL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange